ANTI NMDA RECEPTOR ENCEPHALITIS IGG ANTIBODIES - CSF

The Anti-NMDA Receptor Encephalitis IgG Antibodies (CSF) Test is a specialized laboratory test that detects Immunoglobulin G (IgG) antibodies against the N-Methyl-D-Aspartate (NMDA) receptor in cerebrospinal fluid (CSF). These antibodies are highly associated with Anti-NMDA Receptor Encephalitis, a serious but potentially treatable autoimmune neurological disorder in which the immune system attacks NMDA receptors in the brain.

The NMDA receptor plays a vital role in learning, memory, and normal brain function. When these antibodies attack the receptor, patients may develop psychiatric symptoms, seizures, cognitive impairment, movement disorders, speech abnormalities, autonomic dysfunction, and reduced consciousness.

CSF testing is considered more sensitive and clinically valuable than serum testing for detecting Anti-NMDA Receptor antibodies. Therefore, CSF antibody analysis is often recommended when autoimmune encephalitis is strongly suspected.

Benefits of the Test

• Detects Anti-NMDA Receptor IgG antibodies in cerebrospinal fluid.
• Supports early diagnosis of autoimmune encephalitis.
• Provides higher diagnostic sensitivity than serum testing.
• Helps evaluate unexplained psychiatric and neurological symptoms.
• Assists neurologists in treatment planning.
• Supports monitoring when interpreted with clinical findings and imaging.

Why Doctors Recommend This Test

Doctors may recommend the Anti-NMDA Receptor Encephalitis IgG Antibodies (CSF) Test for patients with symptoms such as:

• Sudden behavioral or personality changes
• Hallucinations or psychosis
• Memory loss
• New-onset seizures
• Confusion or altered mental status
• Difficulty speaking
• Involuntary movements
• Muscle rigidity
• Reduced consciousness
• Suspected autoimmune encephalitis

The test is commonly performed along with MRI Brain, Electroencephalogram (EEG), routine CSF analysis, CSF cell count, CSF protein and glucose, autoimmune encephalitis antibody panels, and other neurological investigations.

Preparation Before Test

• No fasting is generally required.
• Inform your physician about medications, bleeding disorders, or blood-thinning medications before lumbar puncture.
• CSF is collected by a qualified healthcare professional using a lumbar puncture (spinal tap) under sterile conditions.
• Follow your physician's instructions before and after the procedure.

Normal Reporting Time

Reporting Time: Usually 5–10 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected Anti-NMDA Receptor Encephalitis.
• Patients with unexplained encephalopathy.
• Individuals with seizures and psychiatric symptoms.
• Patients with unexplained cognitive decline.
• Individuals with suspected autoimmune neurological disorders.
• Patients referred by neurologists or infectious disease specialists.

Patient-Friendly Summary

The Anti-NMDA Receptor Encephalitis IgG Antibodies (CSF) Test examines cerebrospinal fluid (CSF) to detect antibodies that attack NMDA receptors in the brain. These antibodies can cause Anti-NMDA Receptor Encephalitis, an autoimmune condition that may lead to personality changes, hallucinations, seizures, memory loss, abnormal movements, speech problems, and altered consciousness. Because antibodies are often more readily detected in CSF than in blood, this test is considered one of the most valuable laboratory investigations for confirming the diagnosis. Early diagnosis allows timely treatment, which can significantly improve recovery in many patients.